Lv1
42 积分 2022-09-03 加入
CX3CL1: a key switch of cell death immunogenicity
1个月前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
3个月前
已完结
OA08.04 Primary Endpoint Results from SHERLOCK: a Phase 2 trial of Sotorasib, Bevacizumab and Chemotherapy in Advanced KRAS G12C NSCLC
8个月前
已关闭
AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer
9个月前
已完结
Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
9个月前
已完结
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy
9个月前
已完结
Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study
9个月前
已完结
Comparative genomic landscape of acquired resistance in pancreatic cancer treated with pan-RAS or KRASG12C inhibitors
10个月前
已关闭
Data from Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type-I IFN Signaling
1年前
已完结
皖公网安备34019202002308
